Dr Artur Jurczyszyn, MD PhD - Department of Hematology University Hospital

Dr Artur Jurczyszyn

MD PhD

Department of Hematology University Hospital

Poland

ORCID logohttps://orcid.org/0000-0001-9796-8365

Dr Artur Jurczyszyn, MD PhD - Department of Hematology University Hospital

Dr Artur Jurczyszyn

MD PhD

Introduction

Primary Affiliation: Department of Hematology University Hospital - Poland

Metrics

Number of Publications

14

Publications

Number of Profile Views

444

Profile Views

Number of Article Reads

123

Reads

Number of Citations

51

Citations

Top co-authors

Aleksander B Skotnicki
Aleksander B Skotnicki

Jagiellonian University Medical College

7
Sebastian Grosicki
Sebastian Grosicki

Medical University

3
Jacek Czepiel
Jacek Czepiel

Jagiellonian University Medical College

2
Teresa Wolska-Smolen
Teresa Wolska-Smolen

Medical University of Lublin

2
Kazuyuki Shimizu
Kazuyuki Shimizu

Tokai Central Hospital

1
Noopur Raje
Noopur Raje

Dana-Farber Cancer Institute

1
Ingemar Turesson
Ingemar Turesson

Malmö University Hospital

1
Orhan Sezer
Orhan Sezer

Universitätsklinikum Charité

1

Publications

14Publications

123Reads

51PubMed Central Citations

A fatal case of acquired hemophagocytic lymphohistiocytosis (macrophage activation syndrome) in the initial course of dermatomyositis with anti-Jo-1 antibody.

Int J Rheum Dis 2017 Dec 30;20(12):2171-2174. Epub 2013 Sep 30.

Second Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.

View Article
December 2017
5 Reads
1 Citation
1.770 Impact Factor

Bortezomib for the treatment of multiple myeloma.

Expert Rev Hematol 2014 Apr;7(2):173-85

Department of Hematology, Community Hospital in Chorzow, Chorzow, Poland.

View Article
April 2014
4 Reads
3 Citations

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Cancer Epidemiol Biomarkers Prev 2014 Apr 12;23(4):670-4. Epub 2014 Feb 12.

Authors' Affiliations: Genomic Epidemiology Group, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Cracow University Hospital, Cracow; Medical University of Łodz; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łodz; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce, Poland; Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; Morales Meseguer General University Hospital, Murcia; University Hospital of Salamanca, Salamanca; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government; Hematology Department, Virgen de las Nieves University Hospital, Granada; IDIBELL-Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; Semmelweis University, Budapest, Hungary; Institut National de la Santé et de la Recherche Medicale (INSERM) UMR 1052/CNRS 5286, Université Claude Bernard Lyon I, Lyon; Genetic Epidemiology of Cancer team, INSERM, U900, Institut Curie, Mines ParisTech, Paris, France; Department of Biology, University of Pisa, Pisa, Italy; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg; Organ Center, Hospital of Southern Jutland, Aabenraa; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense C; National Research Centre for the Working Environment, Copenhagen; Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Life and Health Sciences Research Institute, University of Minho, Braga; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; UO Hematology, Department of Internal and Experimental Medicine, University of Pisa, Pisa, Italy; and Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

View Article
April 2014
31 Reads
3 Citations
4.120 Impact Factor

Transient cortical blindness after coronary artery angiography.

Postepy Kardiol Interwencyjnej 2013 21;9(1):105-8. Epub 2013 Mar 21.

1 Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.

View Article
February 2014
1 Read
0.070 Impact Factor

Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.

Hematol Oncol 2013 Mar 6;31(1):41-8. Epub 2012 Jun 6.

Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.

View Article
March 2013
12 Reads
9 Citations
3.080 Impact Factor

[Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].

Przegl Lek 2011 ;68(6):320-5

Klinika Hematologii Szpital Uniwersytecki w Krakowie.

View Article
March 2012
10 Reads

[Waldenström's macroglobulinemia--the experts opinion about new therapeutic possibilities and response criteria].

Pol Arch Med Wewn 2004 Sep;112(3):1113-21

Klinika Hematologii CM UJ, Kraków.

View Article
September 2004
4 Reads

[Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].

Przegl Lek 2003 ;60(8):542-7

Katedra i Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellońskiego, 31-501 Kraków, ul. Kopernika 17.

View Article
May 2004
5 Reads

[Hepatocyte growth factor: from diagnosis to clinical application].

Przegl Lek 2003 ;60(6):425-34

Katedra i Klinika Hematologii, Collegium Medicum Uniwersytet Jagielloński w Krakowie.

View Article
May 2004
1 Read

Top co-authors

Aleksander B Skotnicki
Aleksander B Skotnicki

Jagiellonian University Medical College

7
Sebastian Grosicki
Sebastian Grosicki

Medical University

3
Jacek Czepiel
Jacek Czepiel

Jagiellonian University Medical College

2
Teresa Wolska-Smolen
Teresa Wolska-Smolen

Medical University of Lublin

2
Kazuyuki Shimizu
Kazuyuki Shimizu

Tokai Central Hospital

1
Noopur Raje
Noopur Raje

Dana-Farber Cancer Institute

1
Ingemar Turesson
Ingemar Turesson

Malmö University Hospital

1
Orhan Sezer
Orhan Sezer

Universitätsklinikum Charité

1